Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Trial of Tirzepatide for the Treatment of Cannabis Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tirzepatide for Cannabis Use Disorder. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cannabis Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING